Burning Rock Biotech Limited (BNR)
NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 0.8666 |
| Open | 0.8275 |
| Bid | 0.5746 x 200 |
| Ask | 1.0600 x 200 |
| Day's Range | 0.7905 - 0.8399 |
| 52 Week Range | 0.5720 - 3.2500 |
| Volume | |
| Avg. Volume | 49,935 |
| Market Cap | 88.198M |
| Beta (5Y Monthly) | 0.23 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.9600 |
| Earnings Date | May 28, 2024 - Jun 03, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.95 |
- Thomson Reuters StreetEvents
Q4 2023 Burning Rock Biotech Ltd Earnings Call
Q4 2023 Burning Rock Biotech Ltd Earnings Call
GlobeNewswireBurning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
GUANGZHOU, China, March 28, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months and the year ended December 31, 2023. 2023 Business Overview and Recent Updates Corporate Updates Completed profitability-driven organizational optimization, execution towards profita
Simply Wall St.Here's Why Burning Rock Biotech (NASDAQ:BNR) Must Use Its Cash Wisely
We can readily understand why investors are attracted to unprofitable companies. For example, although...
© 2024 Yahoo. All rights reserved.